241 related articles for article (PubMed ID: 17720413)
21. Randomized, multicentre, double-blind, placebo-controlled trial of the use of aprotinin in the repair of ruptured abdominal aortic aneurysm. On behalf of the Joint Vascular Research Group.
Robinson J; Nawaz S; Beard JD
Br J Surg; 2000 Jun; 87(6):754-7. PubMed ID: 10848853
[TBL] [Abstract][Full Text] [Related]
22. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
[TBL] [Abstract][Full Text] [Related]
23. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
[TBL] [Abstract][Full Text] [Related]
24. Aprotinin does not increase the risk of renal failure in cardiac surgery patients.
Furnary AP; Wu Y; Hiratzka LF; Grunkemeier GL; Page US
Circulation; 2007 Sep; 116(11 Suppl):I127-33. PubMed ID: 17846292
[TBL] [Abstract][Full Text] [Related]
25. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
Monedero P; Páramo JA; Carrascosa F; Herrero JI; Hidalgo F; Iribarren MJ; García-Pedrajas F
Rev Esp Anestesiol Reanim; 1995 Mar; 42(3):82-6. PubMed ID: 7539932
[TBL] [Abstract][Full Text] [Related]
26. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
27. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
Tilleman TR; Richards WG; Zellos L; Johnson BE; Jaklitsch MT; Mueller J; Yeap BY; Mujoomdar AA; Ducko CT; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):405-11. PubMed ID: 19619785
[TBL] [Abstract][Full Text] [Related]
28. Low-dose aprotinin in cardiac operations.
Haddad R; Kesrouani C; Nasr W
J Med Liban; 2000; 48(3):157-60. PubMed ID: 11268570
[TBL] [Abstract][Full Text] [Related]
29. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery.
Parvizi R; Azarfarin R; Hassanzadeh S
Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289
[TBL] [Abstract][Full Text] [Related]
30. Factor V Leiden does not affect bleeding in aprotinin recipients after cardiopulmonary bypass.
Boehm J; Grammer JB; Lehnert F; Dietrich W; Wagenpfeil S; Wildhirt SM; Wottke M; Braun S; Lange R; Bauernschmitt R
Anesthesiology; 2007 Apr; 106(4):681-6. PubMed ID: 17413905
[TBL] [Abstract][Full Text] [Related]
31. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
[TBL] [Abstract][Full Text] [Related]
32. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
[TBL] [Abstract][Full Text] [Related]
33. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery.
Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P
Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
[TBL] [Abstract][Full Text] [Related]
35. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
[TBL] [Abstract][Full Text] [Related]
36. Haemostatic effect of aprotinin during craniosynostotic surgery in children.
Gunnarsson I; Hlynsson BÖ; Rosmundsson T; Thorsteinsson A
Acta Anaesthesiol Scand; 2011 Sep; 55(8):1010-4. PubMed ID: 22092167
[TBL] [Abstract][Full Text] [Related]
37. The management of bleeding following surgery requiring hypothermic circulatory arrest.
Rooney SJ; Bonser RS
J Card Surg; 1997; 12(2 Suppl):238-42. PubMed ID: 9271752
[TBL] [Abstract][Full Text] [Related]
38. The effect of aprotinin on blood loss in bilateral total knee arthroplasty.
Kinzel V; Shakespeare D; Derbyshire D
Knee; 2005 Apr; 12(2):107-11. PubMed ID: 15749445
[TBL] [Abstract][Full Text] [Related]
39. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
[TBL] [Abstract][Full Text] [Related]
40. Malignant pleural mesothelioma: surgical management in 285 patients.
Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
